Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Clin Oncol. Nov 24, 2022; 13(11): 918-928
Published online Nov 24, 2022. doi: 10.5306/wjco.v13.i11.918
Figure 1
Figure 1 Flow chart of patient selection based on the inclusion and exclusion criteria. HCC: Hepatocellular carcinoma; MRI: Magnetic resonance imaging.
Figure 2
Figure 2 Segmentation of two different biopsy-proven hepatocellular carcinoma across the largest cross-sectional area of the tumor in the T1-arterial phase and T1-portovenous phase. A: T1-arterial phase; B: T1-portovenous phase.